Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Bibliographic Details
Main Authors:	Jawad, Mays, Yu, Ning, Seedhouse, Claire, Tandon, Karuna, Russell, Nigel H, Pallis, Monica
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488582/

Similar Items

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia
by: Brethon, Benoit, et al.
Published: (2006)

A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells
by: Al-Asadi, Mazin Gh., et al.
Published: (2017)

Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization
by: Jager, Eva, et al.
Published: (2011)

AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin
by: Rosen, David B., et al.
Published: (2013)

Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin
by: Kurimoto, M, et al.
Published: (2013)

Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
by: AZUMA, YOSHIKO, et al.
Published: (2016)

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
by: Lambert, Juliette, et al.
Published: (2014)

Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia
by: Loke, J., et al.
Published: (2014)

Tipifarnib in the treatment of acute myeloid leukemia
by: Thomas, Xavier, et al.
Published: (2007)

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
by: Jiang, Zhiwu, et al.
Published: (2016)

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA
by: Grundy, Martin, et al.
Published: (2011)

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
Published: (1994)

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
by: Karp, Judith E, et al.
Published: (2008)

Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells
by: Pallis, Monica, et al.
Published: (2013)

Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells
by: Pallis, Monica, et al.
Published: (2013)

Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
by: Al-Mawali, Adhra, et al.
Published: (2016)

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
by: Renneville, Aline, et al.
Published: (2014)

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
by: de Witte, Theo, et al.
Published: (2015)

Interest in Determining the CD34+ CD38− Phenotype in the Diagnosis and Prognosis of Acute Leukemia in Abidjan – Côte d’Ivoire
by: Sawadogo, Duni, et al.
Published: (2013)

Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
by: Chotinantakul, Kamonnaree, et al.
Published: (2013)

Effect of DLK1 on tumorigenesis in CD34+CD38− bone marrow cells in myelodysplastic syndromes
by: ZHANG, WEI, et al.
Published: (2013)

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells
by: Kornblau, Steven M., et al.
Published: (2013)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
by: Jiang, Zhiwu, et al.
Published: (2016)

Tipifarnib and tanespimycin show synergic proapoptotic activity in U937 cells
by: Krzykowska-Petitjean, Katarzyna, et al.
Published: (2011)

Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia
by: Raponi, Mitch, et al.
Published: (2004)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger, M, et al.
Published: (2009)

Potential Role of Notch Signalling in CD34+ Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL
by: Aljedai, Abdullah, et al.
Published: (2015)

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin
Published: (1996)

FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
by: Wang, Libing, et al.
Published: (2013)

A novel Lin−CD34+CD38− integrin α2− bipotential megakaryocyte–erythrocyte progenitor population in the human bone marrow
by: Wong, W M, et al.
Published: (2016)

Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
by: Won, Eun Jeong, et al.
Published: (2015)

Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics ABT-199 and ABT-737
by: Yu, Ning, et al.
Published: (2018)

CD‐ROM and Libraries:
by: Louis E., Mays
Published: (1987)

Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation
by: Pallis, Monica, et al.
Published: (2016)

Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
by: Pallis, Monica, et al.
Published: (2016)

Ligation of CD38 suppresses human B lymphopoiesis
Published: (1995)

The Roles of Oxytocin and CD38 in Social or Parental Behaviors
by: Lopatina, Olga, et al.
Published: (2013)

Immuno-targeting the multifunctional CD38 using nanobody
by: Li, Ting, et al.
Published: (2016)

Plerixafor for autologous CD34+ cell mobilization
by: Salman, Huda, et al.
Published: (2011)

Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease
by: Bigalke, Boris, et al.
Published: (2011)